Loading...
•
Jan 31, 2025
Cooper Q1 2025 Earnings Report
CooperCompanies reported revenue growth and improved margins in Q1 2025.
Key Takeaways
CooperCompanies reported Q1 2025 revenue of $964.7 million, a 4% increase year-over-year. The company saw growth across its divisions, with CooperVision revenue up 4% to $646.1 million and CooperSurgical revenue up 3% to $318.6 million. GAAP net income reached $104.3 million, translating to diluted EPS of $0.52, while non-GAAP EPS came in at $0.92. Operating income was $182.0 million, with a 19% operating margin. Free cash flow stood at $101.2 million, driven by strong operational performance.
Total revenue increased 4% year-over-year to $964.7 million.
CooperVision revenue grew 4%, while CooperSurgical revenue rose 3%.
GAAP EPS was $0.52, and non-GAAP EPS increased to $0.92.
Free cash flow reached $101.2 million, reflecting strong cash generation.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
CooperCompanies expects continued revenue growth in fiscal 2025, with an updated EPS outlook.
Positive Outlook
- Total FY 2025 revenue projected between $4.08B and $4.16B.
- CooperVision revenue expected between $2.73B and $2.79B.
- CooperSurgical revenue forecasted between $1.35B and $1.37B.
- Non-GAAP EPS raised to $3.94 - $4.02 for FY 2025.
- Operational efficiency gains expected to support margin improvements.
Challenges Ahead
- Foreign currency fluctuations may impact revenue growth.
- Macroeconomic uncertainties could affect consumer spending.
- Increased regulatory compliance costs may pressure margins.
- Potential supply chain disruptions could impact inventory levels.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...